Major deals, including Johnson & Johnson’s $14.6B Intra-Cellular acquisition, signal renewed dealmaking, supported by nearly ...

Bessemer Venture Partners also participated in the round alongside new strategic investors HonorHealth, Northwestern Medicine and Allina Health. Mudit Garg, CEO of Qventus, sat down with ...

This week on “The Top Line,” we break down the biggest stories out of JPM, from J&J’s blockbuster acquisition of ...

Erin Whaley, Tammy Ward Woffenden and Paul M. Mahoney Jr. of Troutman Pepper Locke LLP discuss key market and legal developments impacting health care delivery that will be top of mind for investors ...

investors, reporters and others make the annual trek to the Westin St. Francis in San Francisco for the J.P. Morgan Healthcare Conference. The Fierce Healthcare team is on the ground at JPM and ...

The efforts are aimed at keeping the roughy 20,000 health care executives and investors safe as well ... officers are on hand throughout the JPM conference. An increased security presence was ...

The JP Morgan healthcare conference has become one of the most important events in the industry calendar – each year one or two CEOs are under particular pressure to convince investors their ...

Healthcare leaders shared insights on various topics, including industry challenges, a new administration and growing their ...

Read here for an analysis of Koninklijke Philips' performance and 2025 outlook, highlighting challenges and revised sales ...

See the rest of our coverage of the JP Morgan Healthcare Conference ... NextRNA is focused on investor meetings at this year’s conference, Verhelle said, because the biotech wants to raise ...

The outcome of the 2024 U.S. election had far-reaching implications for the global investment landscape, especially in the dynamic field of ...

SAN FRANCISCO — The J.P. Morgan Healthcare ... investors blamed their lawyers: “I’d love to tell you, but our attorneys would kill me.” That being said, clear themes often emerge during JPM.